$DYN 8-K SEC Filings

Filed On	Filing
29 Sep 2026	8-K: Regulation FD Disclosure; Other Events Dyne Therapeutics Announces Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1)
29 Jul 2026	8-K: Results of Operations and Financial Condition
22 Jul 2026	8-K: Entry into a Material Definitive Agreement; Other Events
20 Jul 2026	8-K: Other Events
22 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation
17 Jun 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
08 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
03 Jun 2026	8-K: Regulation FD Disclosure; Other Events
11 May 2026	8-K: Results of Operations and Financial Condition
02 Mar 2026	8-K: Results of Operations and Financial Condition
12 Jan 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
23 Dec 2025	8-K: Departure/Election of Directors or Officers; Compensation
10 Dec 2025	8-K: Entry into a Material Definitive Agreement; Other Events
08 Dec 2025	8-K: Creation of a Direct Financial Obligation
08 Dec 2025	8-K: Regulation FD Disclosure; Other Events
05 Nov 2025	8-K: Results of Operations and Financial Condition
02 Oct 2025	8-K: Departure/Election of Directors or Officers; Compensation
04 Aug 2025	8-K: Regulation FD Disclosure; Other Events
28 Jul 2025	8-K: Results of Operations and Financial Condition
01 Jul 2025	8-K: Entry into a Material Definitive Agreement; Other Events

Comments